基于自动实例囊肿分割的新影像衍生生物标志物在常染色体显性多囊肾病预后评估中的效用
研究基于CRISP研究数据,采用自动实例囊肿分割技术量化囊肿体积、囊肿数目、实质体积及囊肿-实质表面积等新影像参数。结果显示总囊肿数目和囊肿-实质表面积对eGFR斜率下降、肾衰竭及CKD 3A、3B、4期的预测优于总肾脏体积。这些可自动获取的新影像生物标志物对未来研究和临床管理有重要价值。
要点
- 自动实例囊肿分割可量化囊肿数目、囊肿-实质表面积等新影像参数。
- 总囊肿数目和囊肿-实质表面积对eGFR下降斜率、肾衰竭及CKD分期的预测优于总肾脏体积。
- 少数大囊肿主导肾脏体积的表型经新参数分层后预后区分更佳。
核心结论
- 自动获取的新影像生物标志物在常染色体显性多囊肾病未来研究和临床管理中具有重要价值。
研究设计与样本
- 基于常染色体显性多囊肾病影像学研究联盟(CRISP)研究数据,探索自动实例囊肿分割所得新参数的效用。
主要发现
- 总囊肿数目和囊肿-实质表面积对估计肾小球滤过率下降斜率、肾衰竭及慢性肾脏病3A、3B、4期的预测优于总肾脏体积。
- 少数大囊肿显著贡献总体肾脏体积的表型经新参数分层后预后预测更佳。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
New image-derived biomarkers for patients affected by autosomal dominant polycystic kidney disease are needed to improve current clinical management. The measurement of total kidney volume (TKV) provides critical information for clinicians to drive care decisions. However, patients with similar TKV may present with very different phenotypes, often requiring subjective decisions based on other factors (e.g., appearance of healthy kidney parenchyma, a few cysts contributing significantly to overall TKV, etc.). In this study, we describe a new technique to individually segment cysts and quantify biometric parameters including cyst volume, cyst number, parenchyma volume, and cyst parenchyma surface area. Using data from the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) study the utility of these new parameters was explored, both quantitatively as well as visually. Total cyst number and cyst parenchyma surface area showed superior prediction of the slope of estimated glomerular filtration rate decline, kidney failure and chronic kidney disease stages 3A, 3B, and 4, compared to TKV. In addition, presentations such as a few large cysts contributing significantly to overall kidney volume were shown to be much better stratified in terms of outcome predictions. Thus, these new image biomarkers, which can be obtained automatically, will have great utility in future studies and clinical care for patients affected by autosomal dominant polycystic kidney disease.
引用
- Gregory AV, Chebib FT, Poudyal B, et al. Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation. Kidney Int. 2023. PMID: 36736536. doi:10.1016/j.kint.2023.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。